Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

The inclusion of N-terminal pro-brain natriuretic peptide(NT-proBNP) in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension(SSC-PAH):

pulmonary hypertension

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 04 February 2014 - 01:30 PM

The inclusion of N-terminal pro-brain natriuretic peptide(NT-proBNP) in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension(SSC-PAH): a cohort study.

 

The combination of NT-proBNP with pulmonary function tests is a sensitive, yet simple and non-invasive, screening strategy for SSc-PAH. PubMed, Arthritis Res Ther, 2013 Nov 19;15(6):R193. (Also see: Pulmonary Hypertension)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)